BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lucendo AJ, Miehlke S, Schlag C, Vieth M, von Arnim U, Molina-infante J, Hartmann D, Bredenoord AJ, Ciriza de los Rios C, Schubert S, Brückner S, Madisch A, Hayat J, Tack J, Attwood S, Mueller R, Greinwald R, Schoepfer A, Straumann A, Tack J, Vanuytsel T, Louis H, Musala C, Miehlke S, Frederking D, Bajbouj M, Schlag C, Nennstiel S, Brückner S, Schmelz R, Heimerl S, Stephan A, Fibbe C, Liedtke (née Laschinsky) N, Keller J, Rosien U, Haag S, Schneider A, Hartmann D, Schmöcker C, Buchholz H, Lammert F, Casper M, Reichert M, Madisch A, Sommer D, Mönnikes H, Stengel M, Schmidtmann M, Müller M, Eckardt A, Wehrmann T, Schubert S, Armerding P, Hofmann WP, Liceni T, von Arnim U, Kandulski A, Weigt J, Börner N, Lutz-vorderbrügge A, Albert J, Zeuzem S, Blumenstein I, Sprinzl K, Hausmann J, Bredenoord A, Bredenoord A, Warners M, Villarin AL, Arias ÁA, Tejero Bustos MÁ, Carrillo Ramos MJ, Olalla Gallardo JM, Tosina RJ, Molina-infante J, Zamorano J, Vaquero CS, Francés SC, Pérez T, Rodriguez T, Ciriza de los Ríos C, Rodríguez-valcárcel FC, Castel de Lucas I, Juan AP, Barenys M, Pons C, Martinez IP, Lauret ME, García AC, Rubio E, Straumann A, Hruz P, Brunner S, Hayat J, Poullis A. Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial. Gastroenterology 2019;157:74-86.e15. [DOI: 10.1053/j.gastro.2019.03.025] [Cited by in Crossref: 63] [Cited by in F6Publishing: 94] [Article Influence: 21.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu X, Xiao X, Liu D, Tan C. A meta-analysis on randomized controlled trials of treating eosinophilic esophagitis with budesonide. Ann Med 2022;54:2078-88. [PMID: 35862288 DOI: 10.1080/07853890.2022.2101689] [Reference Citation Analysis]
2 Aceves SS, Alexander JA, Baron TH, Bredenoord AJ, Day L, Dellon ES, Falk GW, Furuta GT, Gonsalves N, Hirano I, Konda VJA, Lucendo AJ, Moawad F, Peterson KA, Putnam PE, Richter J, Schoepfer AM, Straumann A, McBride DL, Sharma P, Katzka DA. Endoscopic approach to eosinophilic esophagitis: American Society for Gastrointestinal Endoscopy Consensus Conference. Gastrointest Endosc 2022:S0016-5107(22)01725-4. [PMID: 35965102 DOI: 10.1016/j.gie.2022.05.013] [Reference Citation Analysis]
3 Lucendo AJ, Molina-Infante J. Current treatment options and long-term outcomes in patients with eosinophilic esophagitis. Expert Rev Clin Immunol 2022;:1-14. [PMID: 35770955 DOI: 10.1080/1744666X.2022.2096591] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Schupack DA, Johnson K, Akambase JA, Geno D, Lavey C, Lennon RJ, Ravi K, Snyder DL, Katzka DA, Alexander JA. Histologic response to steroids in eosinophilic esophagitis is dependent on delivery compound. Dis Esophagus 2022:doac040. [PMID: 35780320 DOI: 10.1093/dote/doac040] [Reference Citation Analysis]
5 Strauss AL, Falk GW. Refractory eosinophilic esophagitis: what to do when the patient has not responded to proton pump inhibitors, steroids and diet. Curr Opin Gastroenterol 2022;38:395-401. [PMID: 35762699 DOI: 10.1097/MOG.0000000000000842] [Reference Citation Analysis]
6 Dhar A, Haboubi H, Auth M, Attwood S. Eosinophilic oesophagitis: improving diagnosis and therapy – reducing the burden of repeated endoscopy. Frontline Gastroenterol. [DOI: 10.1136/flgastro-2022-102118] [Reference Citation Analysis]
7 Dhar A, Haboubi HN, Attwood SE, Auth MKH, Dunn JM, Sweis R, Morris D, Epstein J, Novelli MR, Hunter H, Cordell A, Hall S, Hayat JO, Kapur K, Moore AR, Read C, Sami SS, Turner PJ, Trudgill NJ. British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults. Gut 2022:gutjnl-2022-327326. [PMID: 35606089 DOI: 10.1136/gutjnl-2022-327326] [Reference Citation Analysis]
8 Dellon ES, Khoury P, Muir AB, Liacouras CA, Safroneeva E, Atkins D, Collins MH, Gonsalves N, Falk GW, Spergel JM, Hirano I, Chehade M, Schoepfer AM, Menard-Katcher C, Katzka DA, Bonis PA, Bredenoord AJ, Geng B, Jensen ET, Pesek RD, Feuerstadt P, Gupta SK, Lucendo AJ, Genta RM, Hiremath G, McGowan EC, Moawad FJ, Peterson KA, Rothenberg ME, Straumann A, Furuta GT, Aceves SS. A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions. Gastroenterology 2022:S0016-5085(22)00287-6. [PMID: 35606197 DOI: 10.1053/j.gastro.2022.03.025] [Reference Citation Analysis]
9 Sher ER, Ross JA, Weine DM, Chandini Arjun A. Current and emerging therapies for eosinophilic esophagitis. Allergy Asthma Proc 2022;43:178-86. [PMID: 35524356 DOI: 10.2500/aap.2022.43.220014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Dellon ES, Khoury P, Muir AB, Liacouras CA, Safroneeva E, Atkins D, Collins MH, Gonsalves N, Falk GW, Spergel JM, Hirano I, Chehade M, Schoepfer AM, Menard-katcher C, Katzka DA, Bonis PA, Bredenoord AJ, Geng B, Jensen ET, Pesek RD, Feuerstadt P, Gupta SK, Lucendo AJ, Genta RM, Hiremath G, Mcgowan EC, Moawad FJ, Peterson KA, Rothenberg ME, Straumann A, Furuta GT, Aceves SS. A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions. Journal of Allergy and Clinical Immunology 2022. [DOI: 10.1016/j.jaci.2022.03.015] [Reference Citation Analysis]
11 Miehlke S, Schlag C, Lucendo AJ, Biedermann L, Vaquero CS, Schmoecker C, Hayat J, Hruz P, Ciriza de Los Rios C, Bredenoord AJ, Vieth M, Schoepfer A, Attwood S, Mueller R, Burrack S, Greinwald R, Straumann A; International EOS-2 Study Group. Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6-week open-label trial of the EOS-2 Programme. United European Gastroenterol J 2022;10:330-43. [PMID: 35412032 DOI: 10.1002/ueg2.12220] [Reference Citation Analysis]
12 Bon L, Safroneeva E, Bussmann C, Biedermann L, Schreiner P, Vavricka SR, Schoepfer AM, McCright-Gill T, Simon HU, Straumann A, Chehade M, Greuter T. Close follow-up is associated with fewer stricture formation and results in earlier detection of histological relapse in the long-term management of eosinophilic esophagitis. United European Gastroenterol J 2022. [PMID: 35384368 DOI: 10.1002/ueg2.12216] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Lucendo AJ. Drug treatment strategies for eosinophilic esophagitis in adults. Expert Opin Pharmacother 2022;:1-14. [PMID: 35379069 DOI: 10.1080/14656566.2022.2060077] [Reference Citation Analysis]
14 Marabotto E, Giannini EG, Zentilin P, Ziola S, Djahandideh Sheijani A, Savarino E, Savarino V. Pharmacotherapies in eosinophilic esophagitis: state of the art. Minerva Gastroenterol (Torino) 2022;68:69-76. [PMID: 35302339 DOI: 10.23736/S2724-5985.21.02781-1] [Reference Citation Analysis]
15 Główczewski A, Krogulska A. Formulations of Topical Steroids in Eosinophilic Esophagitis-Current Treatment and Emerging Possibilities. J Clin Med 2022;11:1454. [PMID: 35268544 DOI: 10.3390/jcm11051454] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Young E, Philpott H. Pathophysiology of Dysphagia in Eosinophilic Esophagitis: Causes, Consequences, and Management. Dig Dis Sci 2022. [PMID: 35230577 DOI: 10.1007/s10620-022-07419-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Dellon ES, Lucendo AJ, Schlag C, Schoepfer AM, Falk GW, Eagle G, Nezamis J, Comer GM, Knoop K, Hirano I. Fluticasone Propionate Orally Disintegrating Tablet (APT-1011) for Eosinophilic Esophagitis: Randomized Controlled Trial. Clin Gastroenterol Hepatol 2022:S1542-3565(22)00139-2. [PMID: 35181572 DOI: 10.1016/j.cgh.2022.02.013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Lucendo AJ, Santander C, Savarino E, Guagnozzi D, Pérez-martínez I, Perelló A, Guardiola-arévalo A, Barrio J, Elena Betoré-glaria M, Gutiérrez-junquera C, Ciriza de los Ríos C, Racca F, Fernández-fernández S, Blas-jhon L, Lund Krarup A, de la Riva S, Naves JE, Carrión S, Rodríguez Oballe JA, García-morales N, Tamarit-sebastián S, Navarro P, Arias Á, Laserna-mendieta EJ, Casabona-francés S, Pérez-fernández T, Llerena Castro R, Ghisa M, Manie D, Pellegatta G, Suárez A, Alcedo J, Gil Simón P, Teresa Palomeque M, Asensio T, Granja-navacerrada A, de Mendoza Guena LH, Rodríguez Sánchez A, Masiques Mas L, Dainese R, Feo-ortega S. EoE CONNECT, the European Registry of Clinical, Environmental, and Genetic Determinants in Eosinophilic Esophagitis: rationale, design, and study protocol of a large-scale epidemiological study in Europe. Therap Adv Gastroenterol 2022;15:175628482210742. [DOI: 10.1177/17562848221074204] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Greuter T, Straumann A, Fernandez-Marrero Y, Germic N, Hosseini A, Yousefi S, Simon D, Collins MH, Bussmann C, Chehade M, Dellon ES, Furuta GT, Gonsalves N, Hirano I, Moawad FJ, Biedermann L, Safroneeva E, Schoepfer AM, Simon HU. Characterization of eosinophilic esophagitis variants by clinical, histological, and molecular analyses: A cross-sectional multi-center study. Allergy 2022. [PMID: 35094416 DOI: 10.1111/all.15233] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Feo-ortega S, Lucendo AJ. Evidence-based treatments for eosinophilic esophagitis: insights for the clinician. Therap Adv Gastroenterol 2022;15:175628482110686. [DOI: 10.1177/17562848211068665] [Reference Citation Analysis]
21 Kuźmiński A, Przybyszewski M, Przybyszewska J, Bartuzi Z. Eosinophilic esophagitis. What diet? How to treat it? The point of view of a gastroenterologist working in a department of allergology. Prz Gastroenterol 2021;16:318-23. [PMID: 34976239 DOI: 10.5114/pg.2021.105163] [Reference Citation Analysis]
22 Beauchemin C, Castonguay A, Chan ES, Dellon ES, Feagan BG, Ma C, Waserman S, Cook J, Claveau D. Economic Evaluation of Budesonide Orodispersible Tablets for the Treatment of Eosinophilic Esophagitis: A Cost-Utility Analysis. Adv Ther 2021;38:5737-51. [PMID: 34699003 DOI: 10.1007/s12325-021-01957-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
23 Ho CN, O'Quinn S, Bailey J, Meyers O, Slagle AF, Dellon ES, Datto C. Development and content validation of a symptom assessment for eosinophilic gastritis and eosinophilic gastroenteritis in adults and adolescents. Orphanet J Rare Dis 2021;16:495. [PMID: 34819137 DOI: 10.1186/s13023-021-02107-6] [Reference Citation Analysis]
24 de Rooij WE, Vlieg-Boerstra B, Warners MJ, Van Ampting MTJ, van Esch BCAM, Eussen SRBM, Bredenoord AJ. Effect of amino acid-based formula added to four-food elimination in adult eosinophilic esophagitis patients: A randomized clinical trial. Neurogastroenterol Motil 2021;:e14291. [PMID: 34792264 DOI: 10.1111/nmo.14291] [Reference Citation Analysis]
25 Ketchem CJ, Thakkar KP, Xue A, Reddy S, Abramson L, Greenberg SB, Abichandani S, Miller TL, Chang NC, Eluri S, Reed CC, Dellon ES. Older patients with eosinophilic esophagitis have high treatment response to topical steroids. Dig Liver Dis 2021:S1590-8658(21)00809-4. [PMID: 34789398 DOI: 10.1016/j.dld.2021.10.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Ruffner MA, Juste L, Muir AB. Medical Management of Eosinophilic Esophagitis in Pediatric Patients. Pediatr Clin North Am 2021;68:1191-204. [PMID: 34736584 DOI: 10.1016/j.pcl.2021.07.014] [Reference Citation Analysis]
27 Ning T, Zhou Y, Xu H, Guo S, Wang K, Yu DG. Orodispersible Membranes from a Modified Coaxial Electrospinning for Fast Dissolution of Diclofenac Sodium. Membranes (Basel) 2021;11:802. [PMID: 34832031 DOI: 10.3390/membranes11110802] [Cited by in Crossref: 6] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
28 Keim VJ, Lutterer A, Geddert H, Gossner L. [Intramural esophageal abscess as a complication of an eosinophilic esophagitis]. Z Gastroenterol 2021;59:1078-82. [PMID: 34638154 DOI: 10.1055/a-1589-6806] [Reference Citation Analysis]
29 Kanikowska A, Hryhorowicz S, Rychter AM, Kucharski MA, Zawada A, Iwanik K, Eder P, Słomski R, Dobrowolska A, Krela-Kaźmierczak I. Immunogenetic, Molecular and Microbiotic Determinants of Eosinophilic Esophagitis and Clinical Practice-A New Perspective of an Old Disease. Int J Mol Sci 2021;22:10830. [PMID: 34639170 DOI: 10.3390/ijms221910830] [Reference Citation Analysis]
30 Muir A, Falk GW. Eosinophilic Esophagitis: A Review. JAMA 2021;326:1310-8. [PMID: 34609446 DOI: 10.1001/jama.2021.14920] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
31 Pesek RD, Greuter T, Lopez-nunez O, Bernieh A, Straumann A, Collins MH. Clinicopathologic Correlations in Eosinophilic Gastrointestinal Disorders. The Journal of Allergy and Clinical Immunology: In Practice 2021;9:3258-66. [DOI: 10.1016/j.jaip.2021.06.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
32 Chehade M, Aceves SS. Treatment of Eosinophilic Esophagitis: Diet or Medication? The Journal of Allergy and Clinical Immunology: In Practice 2021;9:3249-56. [DOI: 10.1016/j.jaip.2021.07.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
33 Camilleri AE, Nag S, Russo AR, Stiles KM, Crystal RG, Pagovich OE. Gene therapy for a murine model of eosinophilic esophagitis. Allergy 2021;76:2740-52. [PMID: 33748982 DOI: 10.1111/all.14822] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Ghoz H, Stancampiano FF, Valery JR, Nordelo K, Malviya B, Lacy BE, Francis D, DeVault K, Bouras E, Krishna M, Palmer WC. Extent of eosinophilic esophagitis predicts response to treatment. Endosc Int Open 2021;9:E1234-42. [PMID: 34447870 DOI: 10.1055/a-1492-2650] [Reference Citation Analysis]
35 Medina AL, Troendle DM, Park JY, Thaker A, Dunbar KB, Cheng E. Eosinophilic esophagitis, Barrett's esophagus and esophageal neoplasms in the pediatric patient: a narrative review. Transl Gastroenterol Hepatol 2021;6:32. [PMID: 34423153 DOI: 10.21037/tgh-20-223] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Schreiner P, Greuter T, Tatu A, Keller DI, Straumann A, Biedermann L. Is There a Role for Topical Swallowed Steroids upon Emergency Room Admission for Suspected Food Bolus Obstruction in Eosinophilic Esophagitis? Dysphagia 2021. [PMID: 34398319 DOI: 10.1007/s00455-021-10354-9] [Reference Citation Analysis]
37 Ketchem CJ, Reed CC, Stefanadis Z, Dellon ES. Treatment with compounded fluticasone suspension improves the clinical, endoscopic, and histologic features of eosinophilic esophagitis. Dis Esophagus 2021;34:doaa120. [PMID: 33306783 DOI: 10.1093/dote/doaa120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
38 Chu DK, Spergel JM, Vickery BP. Management of Eosinophilic Esophagitis During Oral Immunotherapy. J Allergy Clin Immunol Pract 2021;9:3282-7. [PMID: 34325036 DOI: 10.1016/j.jaip.2021.07.017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Dellon ES, Woosley JT, McGee SJ, Moist SE, Shaheen NJ. Utility of major basic protein, eotaxin-3, and mast cell tryptase staining for prediction of response to topical steroid treatment in eosinophilic esophagitis: analysis of a randomized, double-blind, double dummy clinical trial. Dis Esophagus 2020;33:doaa003. [PMID: 32193541 DOI: 10.1093/dote/doaa003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Rokkas T, Niv Y, Malfertheiner P. A Network Meta-Analysis of Randomized Controlled Trials on the Treatment of Eosinophilic Esophagitis in Adults and Children. J Clin Gastroenterol 2021;55:400-10. [PMID: 32398629 DOI: 10.1097/MCG.0000000000001356] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Ma C, Schoepfer AM, Dellon ES, Bredenoord AJ, Chehade M, Collins MH, Feagan BG, Furuta GT, Gupta SK, Hirano I, Jairath V, Katzka DA, Pai RK, Rothenberg ME, Straumann A, Aceves SS, Alexander JA, Arva NC, Atkins D, Biedermann L, Blanchard C, Cianferoni A, Ciriza de Los Rios C, Clayton F, Davis CM, de Bortoli N, Dias JA, Falk GW, Genta RM, Ghaffari G, Gonsalves N, Greuter T, Hopp R, Hsu Blatman KS, Jensen ET, Johnston D, Kagalwalla AF, Larsson HM, Leung J, Louis H, Masterson JC, Menard-Katcher C, Menard-Katcher PA, Moawad FJ, Muir AB, Mukkada VA, Penagini R, Pesek RD, Peterson K, Putnam PE, Ravelli A, Savarino EV, Schlag C, Schreiner P, Simon D, Smyrk TC, Spergel JM, Taft TH, Terreehorst I, Vanuytsel T, Venter C, Vieira MC, Vieth M, Vlieg-Boerstra B, von Arnim U, Walker MM, Wechsler JB, Woodland P, Woosley JT, Yang GY, Zevit N, Safroneeva E; COREOS Collaborators:. Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS). J Allergy Clin Immunol 2021:S0091-6749(21)01059-9. [PMID: 34242635 DOI: 10.1016/j.jaci.2021.07.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
42 Friedlander JA, Fleischer DM, Black JO, Levy M, Rothenberg ME, Smith C, Nguyen N, Pan Z, Furuta GT. Unsedated transnasal esophagoscopy with virtual reality distraction enables earlier monitoring of dietary therapy in eosinophilic esophagitis. J Allergy Clin Immunol Pract 2021:S2213-2198(21)00758-3. [PMID: 34224927 DOI: 10.1016/j.jaip.2021.06.030] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Kaymak T, Hruz P, Niess JH. Immune system and microbiome in the esophagus: implications for understanding inflammatory diseases. FEBS J 2021. [PMID: 34213831 DOI: 10.1111/febs.16103] [Reference Citation Analysis]
44 Dellon ES, Collins MH, Katzka DA, Mukkada VA, Falk GW, Morey R, Goodwin B, Eisner JD, Lan L, Desai NK, Williams J, Hirano I; ORBIT2/SHP621-302 Investigators. Long-Term Treatment of Eosinophilic Esophagitis With Budesonide Oral Suspension. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00684-4. [PMID: 34182150 DOI: 10.1016/j.cgh.2021.06.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
45 Miehlke S, von Arnim U, Schlag C, Labenz J, Madisch A. [Treatment of eosinophilic esophagitis - advancements and perspectives]. Z Gastroenterol 2021;59:869-78. [PMID: 34157757 DOI: 10.1055/a-1429-4192] [Reference Citation Analysis]
46 Safroneeva E, Pan Z, King E, Martin LJ, Collins MH, Yang GY, Capocelli KE, Arva NC, Abonia JP, Atkins D, Bonis PA, Dellon ES, Falk GW, Gonsalves N, Gupta SK, Hirano I, Leung J, Menard-Katcher PA, Mukkada VA, Schoepfer AM, Spergel JM, Wershil BK, Rothenberg ME, Aceves SS, Furuta GT; Consortium of Eosinophilic Gastrointestinal Disease Researchers. Long-Lasting Dissociation of Esophageal Eosinophilia and Symptoms Following Dilation in Adults With Eosinophilic Esophagitis. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00588-7. [PMID: 34062314 DOI: 10.1016/j.cgh.2021.05.049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
47 Ma C, Schoepfer AM, Safroneeva E; COREOS Collaborators., COREOS Collaborators. Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS): An International Multidisciplinary Consensus. Gastroenterology 2021;161:748-55. [PMID: 34022180 DOI: 10.1053/j.gastro.2021.04.080] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
48 Schoepfer AM, Henchoz S, Biedermann L, Schreiner P, Greuter T, Reinhard A, Senn J, Franke A, Burri E, Juillerat P, Simon HU, Straumann A, Safroneeva E, Godat S. Technical feasibility, clinical effectiveness, and safety of esophageal stricture dilation using a novel endoscopic attachment cap in adults with eosinophilic esophagitis. Gastrointest Endosc 2021:S0016-5107(21)01352-3. [PMID: 34004192 DOI: 10.1016/j.gie.2021.05.017] [Reference Citation Analysis]
49 Hirano I, Collins MH, Katzka DA, Mukkada VA, Falk GW, Morey R, Desai NK, Lan L, Williams J, Dellon ES; ORBIT1/SHP621-301 Investigators. Budesonide Oral Suspension Improves Outcomes in Patients With Eosinophilic Esophagitis: Results from a Phase 3 Trial. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00456-0. [PMID: 33887475 DOI: 10.1016/j.cgh.2021.04.022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
50 Monasterio C, Decker A, Schauer F, Büttner N, Schmidt A, Schmitt-Gräff A, Kreisel W. [Esophageal Lichen Planus - an Underdiagnosed Disease]. Z Gastroenterol 2021;59:460-9. [PMID: 33831967 DOI: 10.1055/a-1378-9380] [Reference Citation Analysis]
51 Tytor J, Larsson H, Bove M, Johansson L, Bergquist H. Topically applied mometasone furoate improves dysphagia in adult eosinophilic esophagitis - results from a double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol 2021;56:629-34. [PMID: 33831327 DOI: 10.1080/00365521.2021.1906314] [Reference Citation Analysis]
52 Lucendo AJ, López-Sánchez P. Targeted Therapies for Eosinophilic Gastrointestinal Disorders. BioDrugs 2020;34:477-93. [PMID: 32472465 DOI: 10.1007/s40259-020-00427-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
53 Kook PH. Esophagitis in Cats and Dogs. Vet Clin North Am Small Anim Pract 2021;51:1-15. [PMID: 33187619 DOI: 10.1016/j.cvsm.2020.08.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Fabian E, Gröchenig HP, Bauer PK, Eherer AJ, Gugatschka M, Binder L, Langner C, Fickert P, Krejs GJ. Clinical-Pathological Conference Series from the Medical University of Graz : Case No 171: A 37-year-old engineer with bolus hold-up (esophageal food impaction). Wien Klin Wochenschr 2020;132:551-9. [PMID: 32601726 DOI: 10.1007/s00508-020-01694-x] [Reference Citation Analysis]
55 Mathies D, Oyama T, Steinbrück I, Dumoulin FL. Topical oro-dispersible budesonide tablets for stricture prevention after near circumferential ESD for esophageal squamous cell cancer - a case report. Z Gastroenterol 2021;59:454-6. [PMID: 33735916 DOI: 10.1055/a-1409-1076] [Reference Citation Analysis]
56 Lim AH, Wong S, Nguyen NQ. Eosinophilic Esophagitis and IgG4: Is There a Relationship? Dig Dis Sci 2021. [PMID: 33534011 DOI: 10.1007/s10620-020-06788-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
57 Visaggi P, Savarino E, Sciume G, Chio TD, Bronzini F, Tolone S, Frazzoni M, Pugno C, Ghisa M, Bertani L, Bellini M, Savarino V, Peroni D, Marchi S, de Bortoli N. Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults. Therap Adv Gastroenterol 2021;14:1756284820980860. [PMID: 33613690 DOI: 10.1177/1756284820980860] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
58 Kim SJ, Park MI, Kim GH, Lee MW, Jung K, Lee J, Seol SY, Jee SR, Lee HS, Jang JS, Cha JH; Gyeongnam Society of Neurogastroenterology and Motility. Practice Patterns for Eosinophilic Esophagitis Patients in Busan and Gyeongnam: A Korean Multicenter Database Study. J Neurogastroenterol Motil 2021;27:71-7. [PMID: 32699187 DOI: 10.5056/jnm20069] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Zimmer V. First report of in-tissue esophagogastric transit migration of an over-the-scope clip. Ann Gastroenterol 2021;34:122. [PMID: 33414632 DOI: 10.20524/aog.2020.0539] [Reference Citation Analysis]
60 Lucendo AJ. Nutritional approach to eosinophilic esophagitis: which diet and when. Minerva Gastroenterol (Torino) 2022;68:49-59. [PMID: 33267566 DOI: 10.23736/S2724-5985.20.02797-X] [Reference Citation Analysis]
61 Ghisa M, Laserra G, Maniero D, Marabotto E, Barberio B, Pelizzaro F, Barbuscio I, Zingone F, Savarino V, Savarino E. Eosinophilic esophagitis: from pathophysiology to management. Minerva Gastroenterol (Torino) 2022;68:40-8. [PMID: 33267562 DOI: 10.23736/S2724-5985.20.02780-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 van de Ven SEM, Snijders MJBL, Bruno MJ, Koch AD. Effectiveness of topical budesonide in preventing esophageal strictures after endoscopic resection of esophageal cancer. Endosc Int Open 2020;8:E1795-803. [PMID: 33269312 DOI: 10.1055/a-1266-3423] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 Hao LX, Lu Y, Li T, Gong B. A meta-analysis of efficacy of topical steroids in eosinophilic esophagitis: From the perspective of histologic, clinical, and endoscopic outcome. Gastroenterol Hepatol 2021;44:251-60. [PMID: 33162187 DOI: 10.1016/j.gastrohep.2020.07.010] [Reference Citation Analysis]
64 Dellon ES. Red Between the Lines: Evolution of Eosinophilic Esophagitis as a Distinct Clinicopathologic Syndrome. Dig Dis Sci 2020;65:3434-47. [PMID: 33052498 DOI: 10.1007/s10620-020-06642-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Eluri S, Corder SR, Kim E, Tappata M, Reed CC, Shaheen NJ, Dellon ES. Clinical features and time trends associated with an endoscopically normal esophagus in active eosinophilic esophagitis. Endoscopy 2021;53:886-92. [DOI: 10.1055/a-1284-5891] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
66 Syverson EP, Hait EJ. Treatment for eosinophilic esophagitis. Curr Opin Gastroenterol 2020;36:485-90. [PMID: 33009017 DOI: 10.1097/MOG.0000000000000681] [Reference Citation Analysis]
67 Nennstiel S, Schlag C. Treatment of eosinophlic esophagitis with swallowed topical corticosteroids. World J Gastroenterol 2020; 26(36): 5395-5407 [PMID: 33024392 DOI: 10.3748/wjg.v26.i36.5395] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
68 Attwood S, Epstein J. Eosinophilic oesophagitis: recent advances and practical management. Frontline Gastroenterol 2021;12:644-9. [DOI: 10.1136/flgastro-2019-101313] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Ishimura N, Okimoto E, Shibagaki K, Nagano N, Ishihara S. Similarity and difference in the characteristics of eosinophilic esophagitis between Western countries and Japan. Dig Endosc 2021;33:708-19. [PMID: 32623781 DOI: 10.1111/den.13786] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
70 Greuter T, Godat A, Ringel A, Almonte HS, Schupack D, Mendoza G, McCright-Gill T, Dellon ES, Hirano I, Alexander J, Chehade M, Safroneeva E, Bussmann C, Biedermann L, Schreiner P, Schoepfer AM, Straumann A, Katzka DA. Effectiveness and Safety of High- vs Low-Dose Swallowed Topical Steroids for Maintenance Treatment of Eosinophilic Esophagitis: A Multicenter Observational Study. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31136-8. [PMID: 32798703 DOI: 10.1016/j.cgh.2020.08.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
71 Krause J, Rosenbaum C, Grimm M, Rump A, Keßler R, Hosten N, Weitschies W. The EsoCap-system - An innovative platform to drug targeting in the esophagus. J Control Release 2020;327:1-7. [PMID: 32781172 DOI: 10.1016/j.jconrel.2020.08.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
72 Gonsalves NP, Aceves SS. Diagnosis and treatment of eosinophilic esophagitis. J Allergy Clin Immunol 2020;145:1-7. [PMID: 31910983 DOI: 10.1016/j.jaci.2019.11.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
73 Straumann A, Lucendo AJ, Miehlke S, Vieth M, Schlag C, Biedermann L, Vaquero CS, Ciriza de Los Rios C, Schmoecker C, Madisch A, Hruz P, Hayat J, von Arnim U, Bredenoord AJ, Schubert S, Mueller R, Greinwald R, Schoepfer A, Attwood S; International EOS-2 Study Group. Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis. Gastroenterology 2020;159:1672-1685.e5. [PMID: 32721437 DOI: 10.1053/j.gastro.2020.07.039] [Cited by in Crossref: 16] [Cited by in F6Publishing: 37] [Article Influence: 8.0] [Reference Citation Analysis]
74 Laserna-Mendieta EJ, Casabona S, Guagnozzi D, Savarino E, Perelló A, Guardiola-Arévalo A, Barrio J, Pérez-Martínez I, Lund Krarup A, Alcedo J, de la Riva S, Rey-Iborra E, Santander C, Arias Á, Lucendo AJ; EUREOS EoE CONNECT Research group. Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry. Aliment Pharmacol Ther 2020;52:798-807. [PMID: 32677040 DOI: 10.1111/apt.15957] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 15.0] [Reference Citation Analysis]
75 Bajaj J, Brenner D, Cai Q, Cash B, Crowell M, Dibaise J, Gallegos-orozco J, Gardner T, Gyawali C, Ha C, Holtmann G, Jamil L, Kaplan G, Karsan H, Kinoshita Y, Lebwohl B, Leontiadis G, Lichtenstein G, Longstreth G, Muthusamy V, Oxentenko A, Pimentel M, Pisegna J, Rubenstein J, Russo M, Saini S, Samadder N, Shaukat A, Simren M, Stevens T, Valdovinos M, Vargas H, Spiegel B, Lacy B. Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology. Am J Gastroenterol 2020;115:1007-18. [DOI: 10.14309/ajg.0000000000000709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
76 Reddy A, Ashat D, Murali AR. Recent insights on the use of topical steroids in eosinophilic esophagitis. Expert Rev Gastroenterol Hepatol 2020;14:953-63. [PMID: 32567417 DOI: 10.1080/17474124.2020.1785869] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Sonmez S, Coyle C, Sifrim D, Woodland P. Duration of adhesion of swallowed alginates to distal oesophageal mucosa: implications for topical therapy of oesophageal diseases. Aliment Pharmacol Ther 2020;52:442-8. [PMID: 32548849 DOI: 10.1111/apt.15884] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
78 Larsson H, Attwood S. Eosinophilic esophagitis (EoE); a disease that must not be neglected - implications of esophageal rupture and its management. BMC Gastroenterol 2020;20:185. [PMID: 32527222 DOI: 10.1186/s12876-020-01330-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Miehlke S, Lucendo AJ, Straumann A, Jan Bredenoord A, Attwood S. Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence. Therap Adv Gastroenterol 2020;13:1756284820927282. [PMID: 32565912 DOI: 10.1177/1756284820927282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
80 Gutiérrez Junquera C, Fernández Fernández S, Domínguez-Ortega G, Vila Miravet V, García Puig R, García Romero R, Fernández de Valderrama A, Andradas Rivas R; Grupo de Trabajo de Trastornos Gastrointestinales Eosinofílicos de la Sociedad Española de Gastroenterología, Hepatología y Nutrición Pediátricas (SEGHNP)., Miembros del Grupo de Trabajo de Trastornos Gastrointestinales Eosinofílicos de la Sociedad Española de Gastroenterología, Hepatología., Nutrición Pediátricas (SEGHNP). [Recommendations for the diagnosis and practical management of paediatric eosinophilic oesophagitis]. An Pediatr (Engl Ed) 2020;92:376.e1-376.e10. [PMID: 32471747 DOI: 10.1016/j.anpedi.2020.04.007] [Reference Citation Analysis]
81 . UEG Week 2019 Oral Presentations. United European Gastroenterol J 2019;7:10-188. [PMID: 32213000 DOI: 10.1177/2050640619854670] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
82 Dellon ES, Collins MH, Rothenberg ME, Assouline-Dayan Y, Evans L, Gupta S, Schoepfer A, Straumann A, Safroneeva E, Rodriguez C, Minton N, Hua SY, Hirano I. Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis. Clin Gastroenterol Hepatol 2021;19:473-483.e17. [PMID: 32205221 DOI: 10.1016/j.cgh.2020.03.036] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
83 Hirano I, Safroneeva E, Roumet MC, Comer GM, Eagle G, Schoepfer A, Falk GW. Randomised clinical trial: the safety and tolerability of fluticasone propionate orally disintegrating tablets versus placebo for eosinophilic oesophagitis. Aliment Pharmacol Ther 2020;51:750-9. [PMID: 32149424 DOI: 10.1111/apt.15670] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
84 Chen L, Han X, Xu X, Zhang Q, Zeng Y, Su Q, Liu Y, Sheng Y, Xie X. Optimization and Evaluation of the Thermosensitive In Situ and Adhesive Gel for Rectal Delivery of Budesonide. AAPS PharmSciTech 2020;21:97. [PMID: 32128636 DOI: 10.1208/s12249-020-1631-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
85 Greuter T, Straumann A. Medical algorithm: Diagnosis and treatment of eosinophilic esophagitis in adults. Allergy 2020;75:727-30. [PMID: 31714997 DOI: 10.1111/all.14112] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
86 Laserna-Mendieta EJ, Casabona S, Savarino E, Perelló A, Pérez-Martínez I, Guagnozzi D, Barrio J, Guardiola A, Asensio T, de la Riva S, Ruiz-Ponce M, Rodríguez-Oballe JA, Santander C, Arias Á, Lucendo AJ; EUREOS EoE CONNECT research group. Efficacy of Therapy for Eosinophilic Esophagitis in Real-World Practice. Clin Gastroenterol Hepatol 2020;18:2903-2911.e4. [PMID: 31988045 DOI: 10.1016/j.cgh.2020.01.024] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 15.0] [Reference Citation Analysis]
87 Lucendo AJ. Pharmacological treatments for eosinophilic esophagitis: current options and emerging therapies. Expert Rev Clin Immunol 2020;16:63-77. [PMID: 31842634 DOI: 10.1080/1744666X.2019.1705784] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
88 Hirano I, Furuta GT. Approaches and Challenges to Management of Pediatric and Adult Patients With Eosinophilic Esophagitis. Gastroenterology 2020;158:840-51. [PMID: 31836530 DOI: 10.1053/j.gastro.2019.09.052] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
89 Laquintana V, Asim MH, Lopedota A, Cutrignelli A, Lopalco A, Franco M, Bernkop-schnürch A, Denora N. Thiolated hydroxypropyl-β-cyclodextrin as mucoadhesive excipient for oral delivery of budesonide in liquid paediatric formulation. International Journal of Pharmaceutics 2019;572:118820. [DOI: 10.1016/j.ijpharm.2019.118820] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
90 Greuter T, Hirano I, Dellon ES. Emerging therapies for eosinophilic esophagitis. J Allergy Clin Immunol 2020;145:38-45. [PMID: 31705907 DOI: 10.1016/j.jaci.2019.10.027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
91 . UEG Week 2019 Poster Presentations. United European Gastroenterol J 2019;7:189-1030. [PMID: 32213001 DOI: 10.1177/2050640619854671] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
92 Gómez-Aldana A, Jaramillo-Santos M, Delgado A, Jaramillo C, Lúquez-Mindiola A. Eosinophilic esophagitis: Current concepts in diagnosis and treatment. World J Gastroenterol 2019; 25(32): 4598-4613 [PMID: 31528089 DOI: 10.3748/wjg.v25.i32.4598] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
93 de Rooij WE, Dellon ES, Parker CE, Feagan BG, Jairath V, Ma C, Bredenoord AJ. Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review. Drugs 2019;79:1419-34. [DOI: 10.1007/s40265-019-01173-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
94 Arias Á, Lucendo AJ. Molecular basis and cellular mechanisms of eosinophilic esophagitis for the clinical practice. Expert Review of Gastroenterology & Hepatology 2018;13:99-117. [DOI: 10.1080/17474124.2019.1546120] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]